Current Edition

The Future of Healthcare Ecosystems: The Real-World Impact of IDMP

A lot of lip service has been paid by the IDMP software industry to the potential of data-driven processes beyond regulatory compliance. But the opportunities are very real – and wide-ranging – and pharma companies and their software providers have an important role to play in enabling these advances, through their ambitions for and approach to data-driven information management and transparency. Biotechs, without legacy systems and processes to hold them back, might even lead the way. Frits Stulp at Iperion sets out the enhanced role that could be played by a standardised data-driven ecosystem that’s actively promoted by the pharma industry.

Extract:

The Future of Healthcare Ecosystems: The Real-World Impact of IDMP

A lot of lip service has been paid by the IDMP software industry to the potential of data-driven processes beyond regulatory compliance. But the opportunities are very real – and wide-ranging – and pharma companies and their software providers have an important role to play in enabling these advances, through their ambitions for and approach to data-driven information management and transparency. Biotechs, without legacy systems and processes to hold them back, might even lead the way. Here, Frits Stulp of Iperion – a Deloitte business, sets out the enhanced role that could be played by a standardised data-driven ecosystem that’s actively promoted by the pharma industry.

For pharma process decision-makers, deep within regulatory functions, it’s easy to lose sight of the evolving needs of the people who use their products – from patients themselves, to the clinicians prescribing them, the pharmacies dispensing them, and the payers and insurers approving and settling the bills. Yet these changing needs will and do have a bearing on the choice and use of treatments, their safe application, and their efficacy. And as ambitions grow, to empower patients to have a greater say in and understanding of their own health, pharma companies need to rethink the way that they engage and provide information to the different stakeholders across the healthcare ecosystem, right down to the individuals who need treatment.

Click the download button below to read the complete version of  ‘The Future of Healthcare Ecosystems: The Real-World Impact of IDMP’ by Frits Stulp at Iperion